Aller au contenu principal
Article language
STOLL/SleepBase/Body and sleep

Body and sleep

EEG characteristics and sleep stage transitions

Sleep stages are multimodal patterns and not mere frequency labels.

Your gateway to sleep knowledge

Welcome to SleepBase.

Use your STOLL access to explore in-depth research on better sleep.

No access yet? Speak to your STOLL advisor.

Explore and understand

Discover connections.

Choose an approach, then explore each step with your mouse, keyboard or touch.

N1

Potential contribution

Transition with frequent theta components

Qualitative interpretation. These connections do not establish causality; no product measurements are simulated.

Change perspective

What does this mean in practice?

N1

Transition with frequent theta components

Putting it in context

No single frequency band is sufficient

View four typical signal forms

Model · no product measurement
N2 · schematic spindle

Synthetic EEG-like signal examples for N1, N2, N3, and REM. Amplitude and time axis are didactically simplified. Clinical scoring requires, among other things, suitable EEG, EOG, and EMG leads.

Time → · didactic axisRelative synthetic amplitude

N2 · schematic spindle. The signal shape alone is not sufficient for clinical scoring.

The research question

Understanding the findings.

NREM 1, NREM 2, NREM 3, and REM are distinguished by electrical brain activity, eye movements, and muscle tone. The analysis explains typical EEG characteristics, transitions, and functional significance. The accompanying graphic shows synthetic examples, not diagnostically evaluable EEG recordings.

NREM stages in EEG

During the transition to N1, the alpha activity typical of relaxed wakefulness often decreases; low-amplitude mixed activity with theta components appears. N2 is characterised, among other things, by sleep spindles and K-complexes. Spindles typically lie approximately in the 11 to 16 Hz range. N3 contains pronounced slow activity; clinical scoring uses defined criteria for amplitude, frequency, and the proportion of an epoch. A high delta proportion in any given signal is therefore not yet a complete N3 determination. Derivation, filters, and artefacts influence the visible form.

REM and functional coupling

REM can appear relatively low-amplitude and mixed-frequency in the EEG, thus partly resembling the waking state. Rapid eye movements and strongly reduced tonic muscle tone assist in classification. Local twitching does not exclude REM. Investigations of slow oscillations, spindles, and theta events show precise temporal relationships between neuronal processes. [1, 2] This coupling is functionally more interesting than the idea that each frequency band has a single exclusive task. Memory processing and sensory shielding involve multiple stages and networks.

Transitions and clinical relevance

A hypnogram summarises classified epochs and thus smooths short-term transitions. NREM and REM repeat over the night, though not as a rigid clockwork with always identical cycle lengths. Age, prior sleep pressure, medication, and illnesses alter the distribution. Brief wake phases are not automatically pathological. For clinical questions, fragmentation, respiratory events, movements, and daytime symptoms are often just as important as percentages. A watch without EEG can only indirectly estimate these criteria and must not diagnose a sleep stage disorder alone.

Spectral analysis and epoch classification

A frequency spectrum describes how signal energy is distributed across frequencies. Without additional procedures, it loses part of the temporal information. A short K-complex or a spindle may therefore appear less distinct in an averaged power curve than in the raw signal. Conversely, muscle artefacts create high-frequency components that must not be interpreted as cortical activation. For teaching purposes, the raw signal, spectrum, and stage label are three complementary views. The synthetic accompanying graphic deliberately simplifies this relationship. It contains neither calibrated microvolt values nor all channels required for clinical scoring.

Temporal resolution and biological comparability

Sleep is not a uniform eight-hour state. A measurement depends on which sleep stage it occurs in, how long a person was awake beforehand, and at what point of their internal night they are. The same clock time does not necessarily mean the same biological phase for different chronotypes. For a physiological study, sleep schedule, preceding sleep duration, light, meals, and relevant medications are therefore recorded. A single morning value cannot replace a progression. Conversely, frequent blood draws can disturb sleep itself. Continuous signals require a quality check, defined temporal assignment, and an evaluation of missing sections. Group means smooth out individual peaks and transitions. A schematic curve on the accompanying page therefore shows a temporal relationship; it is not a reference curve from which a person can gauge their health. The appropriate measurement method is determined by the question, not by the number of available sensors.

Causal chains between sleep and bedding products

A plausible chain of effects can be: An environment changes comfort or disturbances, which leads to changed sleep, and changed sleep influences a physiological function. Each connection requires its own evidence. An experiment on sleep deprivation does not automatically prove that a high-quality material improves the same function. Likewise, a molecular mechanism does not yet explain how large a practically achievable benefit in everyday life would be. The examination therefore begins with a clearly defined endpoint and a suitable comparison condition. For a product intervention, temperature, lying comfort, expectations, and sounds should be captured as separately as possible. Otherwise, it remains unclear which component explains the change. A biomarker can be revealing without being a validated substitute for recovery, quality of life, or disease risk. For STOLL, the scientifically sound statement is often narrower than the original hypothesis: A low-disturbance environment can support good sleep; a certain hormone level or disease prevention cannot be guaranteed from this.

Benefits and limitations

Approaches in comparison.

ApproachPotential contributionLimits of the evidence
N1Transition with frequent theta componentsNo single frequency band is sufficient
N2 and N3Spindles, K-complexes, and slow activity respectivelyScoring requires defined signals and criteria
REMMixed EEG, eye movements, and atoniaWake-like EEG alone is not diagnostic

What can be measured.

MetricTestImportant limitation
EEG powerFrequency-related analysisBand limits depend on definition
Stage proportionPSG scoringA percentage value does not describe overall recovery
TransitionsHypnogram and eventsEpoch formation smooths short-term dynamics

From research to application

Guidance for practice.

A reliable test plan

A teaching trial uses separate EEG, EOG, and EMG channels and expressly labels synthetic signals. For research, recordings are assessed by trained evaluators using a documented set of rules. Inter-rater agreement and the proportion of artefacts are reported. Automatic procedures are validated on independent individuals.

Implications for customer advice

STOLL can explain sleep stages in an understandable way, but should not specify an ideal percentage distribution for all customers. Product advice evaluates disturbances and comfort; clinical stage analysis belongs in appropriate diagnostics.

Evidence and practical implementation

For classification, the primary criterion is whether the source examines the exact question asked. A technically precise material measurement can be highly informative for a material property while saying little about sleep or long-term health. A clinical study may show a relevant benefit, but only for the group of people, construction, and duration of use studied. Proximity to the concrete question is therefore just as important as the study design.

Subsequently, comparison conditions, sample size, observation duration, and potential biases are considered. Blinding is often difficult with bedding. Expectations, habituation, and the sequence of tested variants can influence results. In the case of manufacturer funding, transparency and independent replication are particularly helpful; funding alone does not decide for or against the validity of a finding. Small pilot studies are primarily used to formulate a question more precisely and to plan a larger trial.

Statistical significance is not the same as practical importance. A small difference can be mathematically detectable without having a tangible benefit for the person in question. Conversely, a relevant individual improvement may remain statistically uncertain in a small group. Therefore, effect size, uncertainty, and everyday relevant endpoints are assessed together. A blanket score would obscure these differences. The interactive companion page consequently does not use fabricated health scores or simulated figures that appear like measured material data.

For implementation, a concrete goal is first defined, and then the smallest reasonably testable change is selected. The initial state, construction used, and observation period are documented. Feedback should capture both the desired benefit and possible new disadvantages. If several components are changed simultaneously, the attribution of success remains uncertain. An individual comparison can improve personal selection but does not replace a general efficacy study.

A supplier proof should concern the model actually offered and the intended use. Deviations in the cover, topper, base, care, or software can alter the transferability. The consultation openly states such limitations and formulates only the performance covered by data or immediate observation. For medical or legal questions, the relevant professional assessment remains necessary. The practical recommendation of this document is a basis for decision-making and not an individual diagnosis.

Research you can trace

Sources and context.

Research methods and limitations

This paper is a targeted narrative research as of 30 September 2026. The starting point is the specific topic question, scientific publications, and, for technical or legal questions, the relevant original sources. The Word documents provided by the client serve as templates for the professional structure and comparative presentation. Their individual statements have not been adopted without verification. This research is not a systematic comprehensive survey, a meta-analysis, or a product certification.

The sources were checked via accessible publication sites, bibliographic datasets, and available excerpts. A complete article was not accessible for every source. Where only an abstract or excerpt was available, the description is limited to the information discernible therein. Figures are only mentioned within their study context; missing details are not supplemented. A phrase such as "no reliable evidence identified" describes the result of this targeted research and does not prove that no such work exists worldwide.

The source numbers in the text refer to the list at the end. Directly examined findings, mechanistic considerations, and the author's own practical deductions are linguistically separated. Hypothetical cases illustrate the decision-making logic; they are not documented customer experiences. The suggested test plans are original designs. They do not establish a binding standard or a medical treatment process. Statements about a product class are not automatically transferred to individual models.

English translation of the German original. Bibliographic references and Word files remain in their original language.

SleepBase by STOLL · Research status: 30 September 2026
Scientific interpretation with sources and limitations. Not an individual medical diagnosis.